Salicylate for the treatment of Kawasaki disease in children
Sübutlu məlumatların xülasələri
02.08.2017 • Sonuncu dəyişiklik 02.08.2017
Editors
Salicylates are probably not effective for the prevention of coronary artery lesions in children with Kawasaki disease.
A Cochrane review included 1 study with a total of 102 subjects. There was no association between the addition of ASA to IVIG treatment on the rate of coronary artery abnormalities at follow up: prior to 30 days from onset of symptoms (RR 0.97; 95% CI 0.43 to 2.19) or at 30 days post onset of symptoms (RR 1.30; 95% CI 0.37 to 4.56).
Comment:The quality of evidence is downgraded by sparse data and poor methodological quality.
Ədəbiyyat
- Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2006 Oct 18;(4):CD004175 [Last assessed as up-to-date: 3 February 2009].